KEGG   PATHWAY: prob04936
Entry
prob04936                   Pathway                                
Name
Alcoholic liver disease - Phodopus roborovskii (desert hamster)
Description
Alcoholic liver disease (ALD) refers to the damages to the liver and its functions due to alcohol overconsumption. It ranges from simple steatosis to steatohepatitis, cirrhosis, and even hepatocellular carcinoma. Alcohol consumption promotes liver inflammation by increasing the translocation of gut-derived endotoxins to the portal circulation and activating Kupffer cells to produce TNF-alpha through the LPS/Toll like receptor (TLR) 4 pathways. TNF-alpha induces hepatocellular damage. When alcohol intake is chronic and heavy, steatosis is caused via generation of acetaldehyde, reactive oxygen species (ROS) and ER stress. ROS inhibits key hepatic transcriptional regulators such as AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR-alpha), which are responsible for fatty acid oxidation and export via ACC and CPT-1. The blockade of AMPK also leads to overexpression of SREBP-1, resulting in an increase of de novo lipogenesis. Moreover, excessive intracellular ROS production induced by ethanol and its metabolite have a critical role in ethanol-induced apoptosis, which may be the critical process in the exacerbation of ALD. It is inferred that the apoptotic signal derived from ROS that was produced by NOX, is mainly transduced through the JNK and p38 MAPK pathways.
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
prob04936  Alcoholic liver disease
prob04936

Organism
Phodopus roborovskii (desert hamster) [GN:prob]
Gene
127213267  C1qa; complement C1q subcomponent subunit A [KO:K03986]
127213266  C1qb; complement C1q subcomponent subunit B [KO:K03987]
127213268  C1qc; complement C1q subcomponent subunit C [KO:K03988]
127224310  C4a; complement C4-A [KO:K03989]
127216803  C3; complement C3 [KO:K03990]
127212959  C3ar1; C3a anaphylatoxin chemotactic receptor [KO:K04009]
127222816  C5; complement C5 [KO:K03994]
127238800  C5ar1; C5a anaphylatoxin chemotactic receptor 1 [KO:K04010]
127224533  lipopolysaccharide-binding protein [KO:K05399]
127235120  Cd14; monocyte differentiation antigen CD14 [KO:K04391]
127231077  Ly96; lymphocyte antigen 96 isoform X1 [KO:K05400]
127224882  Tlr4; toll-like receptor 4 [KO:K10160]
127231493  Tirap; toll/interleukin-1 receptor domain-containing adapter protein [KO:K05403]
127235106  Myd88; myeloid differentiation primary response protein MyD88 [KO:K04729]
127225991  Irak4; interleukin-1 receptor-associated kinase 4 [KO:K04733] [EC:2.7.11.1]
127217354  Irak1; interleukin-1 receptor-associated kinase 1 isoform X1 [KO:K04730] [EC:2.7.11.1]
127222196  Traf6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
127225789  Tab1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403]
127237647  Tab2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
127224461  Map3k7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
127233576  Chuk; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
127220313  Ikbkb; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
127217362  Ikbkg; NF-kappa-B essential modulator isoform X1 [KO:K07210]
127230598  Nfkbia; NF-kappa-B inhibitor alpha [KO:K04734]
127228707  Rela; transcription factor p65 isoform X1 [KO:K04735]
127222971  Nfkb1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
127224347  Tnf; tumor necrosis factor [KO:K03156]
127221462  Il1b; interleukin-1 beta [KO:K04519]
127235558  Il6; interleukin-6 [KO:K05405]
127232891  Il12a; interleukin-12 subunit alpha [KO:K05406]
127219792  Il12b; interleukin-12 subunit beta [KO:K05425]
127232097  C-X-C motif chemokine 15 [KO:K10030]
127216762  Ticam1; TIR domain-containing adapter molecule 1 isoform X1 [KO:K05842]
127231159  Traf3; TNF receptor-associated factor 3 [KO:K03174]
127236377  Ikbke; inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1 [KO:K07211] [EC:2.7.11.10]
127215702  Tbk1; serine/threonine-protein kinase TBK1 [KO:K05410] [EC:2.7.11.10]
127213691  Irf3; interferon regulatory factor 3 isoform X1 [KO:K05411]
127224801  interferon alpha-9-like [KO:K05414]
127224803  interferon alpha-12-like [KO:K05414]
127224841  interferon alpha-12 [KO:K05414]
127224844  interferon alpha-12 [KO:K05414]
127224845  interferon alpha-13-like [KO:K05414]
127224846  interferon alpha-12-like [KO:K05414]
127224847  interferon alpha-12-like [KO:K05414]
127224848  interferon alpha-12-like [KO:K05414]
127224849  interferon alpha-12-like [KO:K05414]
127224840  Ifnb1; interferon beta [KO:K05415]
127236773  Il17a; interleukin-17A [KO:K05489]
127236115  Il17ra; interleukin-17 receptor A isoform X1 [KO:K05164]
127236127  Il17rc; interleukin-17 receptor C isoform X1 [KO:K05166]
127232100  C-X-C motif chemokine 3 [KO:K05505]
127232102  growth-regulated alpha protein [KO:K05505]
127232104  C-X-C motif chemokine 2 [KO:K05505]
127223236  Faslg; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
127233374  Fas; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390]
127228595  Fadd; FAS-associated death domain protein [KO:K02373]
127213032  Tnfrsf1a; tumor necrosis factor receptor superfamily member 1A [KO:K03158]
127234649  Tradd; tumor necrosis factor receptor type 1-associated DEATH domain protein [KO:K03171]
127226337  Casp8; caspase-8 [KO:K04398] [EC:3.4.22.61]
127220536  Casp3; caspase-3 [KO:K02187] [EC:3.4.22.56]
127229356  Ripk1; receptor-interacting serine/threonine-protein kinase 1 [KO:K02861] [EC:2.7.11.1]
127218171  Tab3; TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 isoform X1 [KO:K12793]
127219200  Srebf1; sterol regulatory element-binding protein 1 isoform X1 [KO:K07197]
127220557  Fasn; fatty acid synthase [KO:K00665] [EC:2.3.1.85]
127221108  Acaca; acetyl-CoA carboxylase 1 [KO:K11262] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
127232421  Scd5; LOW QUALITY PROTEIN: stearoyl-CoA desaturase 5 [KO:K00507] [EC:1.14.19.1]
127233253  stearoyl-CoA desaturase 2 [KO:K00507] [EC:1.14.19.1]
127233254  acyl-CoA desaturase 1 [KO:K00507] [EC:1.14.19.1]
127233255  acyl-CoA desaturase 3 [KO:K00507] [EC:1.14.19.1]
127233529  stearoyl-CoA desaturase 4 [KO:K00507] [EC:1.14.19.1]
127233532  stearoyl-CoA desaturase 2-like [KO:K00507] [EC:1.14.19.1]
127224312  Lpin3; phosphatidate phosphatase LPIN3 [KO:K15728] [EC:3.1.3.4]
127219994  Lpin1; phosphatidate phosphatase LPIN1 isoform X1 [KO:K15728] [EC:3.1.3.4]
127226786  Lpin2; phosphatidate phosphatase LPIN2 isoform X1 [KO:K15728] [EC:3.1.3.4]
127224056  Sirt1; NAD-dependent protein deacetylase sirtuin-1 [KO:K11411] [EC:2.3.1.286]
127235783  Tra2a; transformer-2 protein homolog alpha isoform X1 [KO:K12897]
127226992  Tra2b; transformer-2 protein homolog beta isoform X1 [KO:K12897]
127227011  Adipoq; adiponectin [KO:K07296]
127236224  Adipor2; adiponectin receptor protein 2 [KO:K07297]
127236321  Adipor1; adiponectin receptor protein 1 [KO:K07297]
127216076  Camkk2; calcium/calmodulin-dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]
127224997  Prkaa2; 5'-AMP-activated protein kinase catalytic subunit alpha-2 [KO:K07198] [EC:2.7.11.31]
127220610  Prkaa1; 5'-AMP-activated protein kinase catalytic subunit alpha-1 [KO:K07198] [EC:2.7.11.31]
127216002  Prkab1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
127233006  Prkab2; 5'-AMP-activated protein kinase subunit beta-2 isoform X1 [KO:K07199]
127235796  Prkag2; 5'-AMP-activated protein kinase subunit gamma-2 isoform X1 [KO:K07200]
127226041  Prkag1; 5'-AMP-activated protein kinase subunit gamma-1 [KO:K07200]
127226445  Prkag3; 5'-AMP-activated protein kinase subunit gamma-3 [KO:K07200]
127216298  Foxo1; forkhead box protein O1 [KO:K07201]
127215176  Foxo3; forkhead box protein O3 [KO:K09408]
127213598  Ppargc1a; peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1 [KO:K07202]
127225913  Ppara; peroxisome proliferator-activated receptor alpha [KO:K07294]
127228604  Cpt1a; carnitine O-palmitoyltransferase 1, liver isoform [KO:K08765] [EC:2.3.1.21]
127219014  Acadvl; very long-chain specific acyl-CoA dehydrogenase, mitochondrial [KO:K09479] [EC:1.3.8.9]
127230347  Acadm; medium-chain specific acyl-CoA dehydrogenase, mitochondrial [KO:K00249] [EC:1.3.8.7]
127219391  Acox1; peroxisomal acyl-coenzyme A oxidase 1 isoform X1 [KO:K00232] [EC:1.3.3.6]
127233660  Acox3; peroxisomal acyl-coenzyme A oxidase 3 [KO:K00232] [EC:1.3.3.6]
127235536  Fabp1; fatty acid-binding protein, liver [KO:K08750]
127222933  alcohol dehydrogenase 1 [KO:K13951] [EC:1.1.1.1]
127222934  alcohol dehydrogenase 1-like [KO:K13951] [EC:1.1.1.1]
127222940  alcohol dehydrogenase 1-like [KO:K13951] [EC:1.1.1.1]
127222943  LOW QUALITY PROTEIN: alcohol dehydrogenase 1-like [KO:K13951] [EC:1.1.1.1]
127222945  LOW QUALITY PROTEIN: all-trans-retinol dehydrogenase [NAD(+)] ADH7-like [KO:K13951] [EC:1.1.1.1]
127223141  LOW QUALITY PROTEIN: all-trans-retinol dehydrogenase [NAD(+)] ADH7-like [KO:K13951] [EC:1.1.1.1]
127217922  alcohol dehydrogenase 1-like [KO:K13951] [EC:1.1.1.1]
127222938  Adh4; all-trans-retinol dehydrogenase [NAD(+)] ADH4 [KO:K13980] [EC:1.1.1.1]
127217125  all-trans-retinol dehydrogenase [NAD(+)] ADH4-like [KO:K13980] [EC:1.1.1.1]
127222936  Adh5; alcohol dehydrogenase class-3 isoform X1 [KO:K00121] [EC:1.1.1.284 1.1.1.1]
127222937  alcohol dehydrogenase 6-like isoform X1 [KO:K13952] [EC:1.1.1.1]
127217025  alcohol dehydrogenase 6 [KO:K13952] [EC:1.1.1.1]
127216053  Aldh2; aldehyde dehydrogenase, mitochondrial [KO:K00128] [EC:1.2.1.3]
127224628  Aldh1b1; aldehyde dehydrogenase X, mitochondrial [KO:K00128] [EC:1.2.1.3]
127219173  Aldh3a2; aldehyde dehydrogenase family 3 member A2 isoform X1 [KO:K00128] [EC:1.2.1.3]
127234058  Aldh7a1; alpha-aminoadipic semialdehyde dehydrogenase isoform X1 [KO:K14085] [EC:1.2.1.31 1.2.1.8 1.2.1.3]
127223537  Aldh9a1; 4-trimethylaminobutyraldehyde dehydrogenase isoform X1 [KO:K00149] [EC:1.2.1.47 1.2.1.3]
127228509  cytochrome P450 2E1 [KO:K07415] [EC:1.14.14.-]
127215967  Acacb; acetyl-CoA carboxylase 2 [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
127234414  Mlycd; malonyl-CoA decarboxylase, mitochondrial [KO:K01578] [EC:4.1.1.9]
127225959  Cpt1b; carnitine O-palmitoyltransferase 1, muscle isoform [KO:K19523] [EC:2.3.1.21]
127213870  Cpt1c; carnitine O-palmitoyltransferase 1, brain isoform [KO:K19524] [EC:2.3.1.21]
127227236  Nox4; NADPH oxidase 4 isoform X1 [KO:K21423] [EC:1.6.3.-]
127223664  Akt3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
127231187  Akt1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
127239025  Akt2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
127227159  Gsk3b; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
127235353  Ctnnb1; catenin beta-1 [KO:K02105]
127219310  Tcf7; transcription factor 7 isoform X1 [KO:K02620]
127235531  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
127233545  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
127223025  Lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
127228599  Ccnd1; G1/S-specific cyclin-D1 [KO:K04503]
127215051  Map3k5; mitogen-activated protein kinase kinase kinase 5 isoform X1 [KO:K04426] [EC:2.7.11.25]
127219129  Map2k4; dual specificity mitogen-activated protein kinase kinase 4 isoform X1 [KO:K04430] [EC:2.7.12.2]
127237193  Map2k7; dual specificity mitogen-activated protein kinase kinase 7 isoform X1 [KO:K04431] [EC:2.7.12.2]
127235390  Mapk8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
127219360  Mapk9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
127232178  Mapk10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
127219179  Map2k3; dual specificity mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
127218712  Map2k6; dual specificity mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
127224210  Mapk13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
127224217  Mapk14; mitogen-activated protein kinase 14 isoform X1 [KO:K04441] [EC:2.7.11.24]
127225455  mitogen-activated protein kinase 13-like [KO:K04441] [EC:2.7.11.24]
127225941  Mapk12; mitogen-activated protein kinase 12 isoform X1 [KO:K04441] [EC:2.7.11.24]
127225942  Mapk11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
127216792  Map3k14; mitogen-activated protein kinase kinase kinase 14 [KO:K04466] [EC:2.7.11.25]
Compound
C00003  NAD+
C00005  NADPH
C00006  NADP+
C00024  Acetyl-CoA
C00033  Acetate
C00040  Acyl-CoA
C00076  Calcium cation
C00083  Malonyl-CoA
C00084  Acetaldehyde
C00469  Ethanol
C22381  Reactive oxygen species
Reference
  Authors
Louvet A, Mathurin P
  Title
Alcoholic liver disease: mechanisms of injury and targeted treatment.
  Journal
Nat Rev Gastroenterol Hepatol 12:231-42 (2015)
DOI:10.1038/nrgastro.2015.35
Reference
  Authors
Gao B, Bataller R
  Title
Alcoholic liver disease: pathogenesis and new therapeutic targets.
  Journal
Gastroenterology 141:1572-85 (2011)
DOI:10.1053/j.gastro.2011.09.002
Reference
  Authors
Magdaleno F, Blajszczak CC, Nieto N
  Title
Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.
  Journal
Biomolecules 7:E9 (2017)
DOI:10.3390/biom7010009
Reference
  Authors
Lucey MR, Mathurin P, Morgan TR
  Title
Alcoholic hepatitis.
  Journal
N Engl J Med 360:2758-69 (2009)
DOI:10.1056/NEJMra0805786
Reference
  Authors
Nagy LE, Ding WX, Cresci G, Saikia P, Shah VH
  Title
Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.
  Journal
Gastroenterology 150:1756-68 (2016)
DOI:10.1053/j.gastro.2016.02.035
Reference
  Authors
Fujii H, Kawada N
  Title
Fibrogenesis in alcoholic liver disease.
  Journal
World J Gastroenterol 20:8048-54 (2014)
DOI:10.3748/wjg.v20.i25.8048
Reference
  Authors
Kim MS, Ong M, Qu X
  Title
Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
  Journal
World J Gastroenterol 22:8-23 (2016)
DOI:10.3748/wjg.v22.i1.8
Reference
  Authors
You M, Crabb DW
  Title
Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.
  Journal
Am J Physiol Gastrointest Liver Physiol 287:G1-6 (2004)
DOI:10.1152/ajpgi.00056.2004
Reference
  Authors
Nagy LE
  Title
The Role of Innate Immunity in Alcoholic Liver Disease.
  Journal
Alcohol Res 37:237-50 (2015)
Reference
  Authors
Gao B, Seki E, Brenner DA, Friedman S, Cohen JI, Nagy L, Szabo G, Zakhari S
  Title
Innate immunity in alcoholic liver disease.
  Journal
Am J Physiol Gastrointest Liver Physiol 300:G516-25 (2011)
DOI:10.1152/ajpgi.00537.2010
Reference
  Authors
Wang HJ, Gao B, Zakhari S, Nagy LE
  Title
Inflammation in alcoholic liver disease.
  Journal
Annu Rev Nutr 32:343-68 (2012)
DOI:10.1146/annurev-nutr-072610-145138
Reference
  Authors
McCullough RL, McMullen MR, Sheehan MM, Poulsen KL, Roychowdhury S, Chiang DJ, Pritchard MT, Caballeria J, Nagy LE
  Title
Complement Factor D protects mice from ethanol-induced inflammation and liver injury.
  Journal
Am J Physiol Gastrointest Liver Physiol 315:G66-G79 (2018)
DOI:10.1152/ajpgi.00334.2017
Reference
  Authors
Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H
  Title
The effect of inflammatory cytokines in alcoholic liver disease.
  Journal
Mediators Inflamm 2013:495156 (2013)
DOI:10.1155/2013/495156
Reference
  Authors
Szabo G, Bala S
  Title
Alcoholic liver disease and the gut-liver axis.
  Journal
World J Gastroenterol 16:1321-9 (2010)
DOI:10.3748/wjg.v16.i11.1321
Reference
  Authors
Kawaratani H, Moriya K, Namisaki T, Uejima M, Kitade M, Takeda K, Okura Y, Kaji K, Takaya H, Nishimura N, Sato S, Sawada Y, Seki K, Kubo T, Mitoro A, Yamao J, Yoshiji H
  Title
Therapeutic strategies for alcoholic liver disease: Focusing on inflammation and fibrosis (Review).
  Journal
Int J Mol Med 40:263-270 (2017)
DOI:10.3892/ijmm.2017.3015
Reference
  Authors
Roh YS, Seki E
  Title
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
  Journal
J Gastroenterol Hepatol 28 Suppl 1:38-42 (2013)
DOI:10.1111/jgh.12019
Reference
  Authors
Rogers CQ, Ajmo JM, You M
  Title
Adiponectin and alcoholic fatty liver disease.
  Journal
IUBMB Life 60:790-7 (2008)
DOI:10.1002/iub.124
Reference
  Authors
You M, Jogasuria A, Lee K, Wu J, Zhang Y, Lee YK, Sadana P
  Title
Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.
  Journal
Curr Mol Pharmacol 10:226-236 (2017)
DOI:10.2174/1874467208666150817112109
Reference
  Authors
You M, Jogasuria A, Taylor C, Wu J
  Title
Sirtuin 1 signaling and alcoholic fatty liver disease.
  Journal
Hepatobiliary Surg Nutr 4:88-100 (2015)
DOI:10.3978/j.issn.2304-3881.2014.12.06
Reference
  Authors
Ren R, Wang Z, Wu M, Wang H
  Title
Emerging Roles of SIRT1 in Alcoholic Liver Disease.
  Journal
Int J Biol Sci 16:3174-3183 (2020)
DOI:10.7150/ijbs.49535
Reference
  Authors
Purohit V, Gao B, Song BJ
  Title
Molecular mechanisms of alcoholic fatty liver.
  Journal
Alcohol Clin Exp Res 33:191-205 (2009)
DOI:10.1111/j.1530-0277.2008.00827.x
Reference
  Authors
Hyun J, Han J, Lee C, Yoon M, Jung Y
  Title
Pathophysiological Aspects of Alcohol Metabolism in the Liver.
  Journal
Int J Mol Sci 22:5717 (2021)
DOI:10.3390/ijms22115717
Reference
  Authors
Combs TP, Marliss EB
  Title
Adiponectin signaling in the liver.
  Journal
Rev Endocr Metab Disord 15:137-47 (2014)
DOI:10.1007/s11154-013-9280-6
Reference
  Authors
Ceni E, Mello T, Galli A
  Title
Pathogenesis of alcoholic liver disease: role of oxidative metabolism.
  Journal
World J Gastroenterol 20:17756-72 (2014)
DOI:10.3748/wjg.v20.i47.17756
Reference
  Authors
Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T
  Title
Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
  Journal
Int J Mol Sci 20:E2712 (2019)
DOI:10.3390/ijms20112712
Reference
  Authors
Ohashi K, Pimienta M, Seki E
  Title
Alcoholic liver disease: A current molecular and clinical perspective.
  Journal
Liver Res 2:161-172 (2018)
DOI:10.1016/j.livres.2018.11.002
Reference
  Authors
You M, Arteel GE
  Title
Effect of ethanol on lipid metabolism.
  Journal
J Hepatol 70:237-248 (2019)
DOI:10.1016/j.jhep.2018.10.037
Reference
  Authors
Bi L, Jiang Z, Zhou J
  Title
The role of lipin-1 in the pathogenesis of alcoholic fatty liver.
  Journal
Alcohol Alcohol 50:146-51 (2015)
DOI:10.1093/alcalc/agu102
Reference
  Authors
Ali H, Assiri MA, Shearn CT, Fritz KS
  Title
Lipid peroxidation derived reactive aldehydes in alcoholic liver disease.
  Journal
Curr Opin Toxicol 13:110-117 (2019)
DOI:10.1016/j.cotox.2018.10.003
Reference
  Authors
Yin H, Hu M, Liang X, Ajmo JM, Li X, Bataller R, Odena G, Stevens SM Jr, You M
  Title
Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.
  Journal
Gastroenterology 146:801-11 (2014)
DOI:10.1053/j.gastro.2013.11.008
Reference
  Authors
Stickel F, Hampe J
  Title
Genetic determinants of alcoholic liver disease.
  Journal
Gut 61:150-9 (2012)
DOI:10.1136/gutjnl-2011-301239
Reference
  Authors
Yang CF, Zhong YJ, Ma Z, Li L, Shi L, Chen L, Li C, Wu D, Chen Q, Li YW
  Title
NOX4/ROS mediate ethanolinduced apoptosis via MAPK signal pathway in L02 cells.
  Journal
Int J Mol Med 41:2306-2316 (2018)
DOI:10.3892/ijmm.2018.3390
Related
pathway
prob00061  Fatty acid biosynthesis
prob00071  Fatty acid degradation
prob01040  Biosynthesis of unsaturated fatty acids
prob03040  Spliceosome
prob04010  MAPK signaling pathway
prob04064  NF-kappa B signaling pathway
prob04152  AMPK signaling pathway
prob04210  Apoptosis
prob04310  Wnt signaling pathway
prob04610  Complement and coagulation cascades
prob04620  Toll-like receptor signaling pathway
prob04657  IL-17 signaling pathway
prob04668  TNF signaling pathway
prob04920  Adipocytokine signaling pathway
prob05034  Alcoholism
prob05225  Hepatocellular carcinoma
KO pathway
ko04936   
LinkDB

DBGET integrated database retrieval system